Avid Bioservices Inc (CDMO)

[Carboat]

MSK and NCCN, besides AstraZeneca, are now ALSO involved in setting out a pathway for bavituximab. A strange and in my opinion stupid effort for a drug that so many claim doesn't work. You'd think they have better things to do at MSK, NCCN and AZ then playing kindergarten with PPHM, wouldn't they?

PPHM is paying these people remember. So the bar is relatively low. And even in these selective vanity labs few of the projects find their way into the market and even fewer become blockbusters.